Compare BCRX & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BCRX | WB |
|---|---|---|
| Founded | 1986 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 1.7B |
| IPO Year | 1995 | 2014 |
| Metric | BCRX | WB |
|---|---|---|
| Price | $7.20 | $5.23 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 11 | 16 |
| Target Price | ★ $20.45 | $7.07 |
| AVG Volume (30 Days) | ★ 4.5M | 1.1M |
| Earning Date | 11-04-2026 | 11-17-2026 |
| Dividend Yield | N/A | ★ 11.45% |
| EPS Growth | ★ 381.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $25,186,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3.71 | N/A |
| P/E Ratio | ★ N/A | $5.66 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $6.23 | $5.27 |
| 52 Week High | $11.22 | $11.28 |
| Indicator | BCRX | WB |
|---|---|---|
| Relative Strength Index (RSI) | 35.29 | 18.38 |
| Support Level | N/A | N/A |
| Resistance Level | $8.83 | $6.68 |
| Average True Range (ATR) | 0.37 | 0.18 |
| MACD | -0.05 | -0.11 |
| Stochastic Oscillator | 0.87 | 0.70 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Weibo Corp is a China-based company that operates a social media platform for people to create, discover and distribute content. The company currently operates and manages its business in two principal business lines globally - advertising and marketing services and value-added services. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The company's main product is the social platform Weibo. It generates a substantial majority of its revenues from online advertising and marketing services.